We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · November 03, 2021

Effect of Initiating Biologics vs Intensifying Conventional DMARDs on Clinical and MRI Outcomes in Established RA Patients in Clinical Remission

Scandinavian Journal of Rheumatology


Additional Info

Scandinavian Journal of Rheumatology
Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial
Scand J Rheumatol 2021 Sep 02;[EPub Ahead of Print], S Møller-Bisgaard, K Hørslev-Petersen, B Ejbjerg, ML Hetland, R Christensen, LM Ørnbjerg, D Glinatsi, JM Møller, M Boesen, K Stengaard-Pedersen, OR Madsen, B Jensen, JA Villadsen, EM Hauge, P Bennett, O Hendricks, K Asmussen, M Kowalski, H Lindegaard, H Bliddal, NS Krogh, T Ellingsen, AH Nielsen, L Larsen, AG Jurik, HS Thomsen, M Østergaard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading